G9090

Oncology; disease status; rectal cancer, limited to invasive cancer, adenocarcinoma as predominant cell type; extent of disease initially established as t1-2, n0, m0 (prior to neo-adjuvant therapy, if any) with no evidence of disease progression, recurrence, or metastases (for use in a medicare-appr

Short Description: Onc dx rectal t1-2 no progr

Coverage Code: Carrier judgment

Action Code: No maintenance for this code

Date Added: January 1, 2006

Effective Date: January 1, 2007

Termination Date:

Search
Generic filters